BIOHIT HEALTHCARE develops, manufactures, and markets cost-effective and innovative diagnostic tests for the screening, diagnosis, monitoring and prevention of gastrointestinal disease.
These include:
• Faecal Calprotectin – Exclude inflammatory conditions and improve the predictive value of referral criteria in patients with changes in bowel habit.
• TNF??blocker assays – monitor drug levels for Adalimumab and Infliximab.
• Pepsinogen Profile – make appropriate and prioritized referrals for gastroscopy by excluding organic gastric disease.
• Acetium – oral capsule for the binding and neutralising of carcinogenic Acetaldehyde in the low- or anacidic stomach.
• H. pylori Quick Test – the essential 30 minute (maximum) rapid urease test for biopsies.
• Lactose Intolerance Quick Test – 20 minute endoscopy biopsy test to determine duodenal lactase deficiency.
